Researchers have found a link between low testosterone levels and aggressive tumors, which could change how prostate cancer ...

Houston-based University of Texas MD Anderson Cancer Center has opened a colorectal cancer center.  The facility brings subspecialty colorectal cancer care services together in one location. It houses ...

Low testosterone levels may increase the risk of higher-grade “extreme” progression of prostate cancer among men enrolled in active surveillance (AS), acc ...

An ultrasound-based treatment for prostate cancer showed better safety and operative metrics versus robotic radical ...

The GPS Mdx test is a 17-gene expression assay performed on prostate biopsy tissue that may identify signals of favorable vs unfavorable pathology.

HOUSTON, MARCH 18, 2026 ― At The University of Texas MD Anderson Cancer Center , research breakthroughs are made possible through seamless ...

NEW ORLEANS - Ochsner MD Anderson Cancer Center will be the first in the South to offer Biology-Guided Radiotherapy, joining ...

A new study led by researchers at The University of Texas MD Anderson Cancer Center found that prostate cancer patients with low testosterone levels may have a higher risk of cancer progressing to a ...

The new treatment uses the unique biology of the cancer itself to guide radiotherapy delivery, even in tumors that are in motion.

An investigational approach to diagnosis of prostate cancer uses sound waves to extract "bubbles of information" from cells. (Cancer Research UK) In a first-ever clinical trial, a treatment strategy ...

Please provide your email address to receive an email when new articles are posted on . Pylarify TruVu is a new formulation of piflufolastat F 18 injection, which originally earned FDA approval in ...